Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) -- Ignore unavailable to you. Want to Upgrade?

To: Marvin L.Covey who wrote (252)	7/23/1999 2:53:00 PM
From: John Romeo	Respond to of 513

How and what it holds near close is critical. At 2:48 quite a large number of shares to sell at 3, 3 1/8 . MM's on bid are mostly 100 shares or 1000. ISLD has an order working on the books 8300 to sell at 3 1/32.I check back after close. Where it goes from here is important. Happy to see CNBC bring it up during Nasdaq Briefing. This Rotavirus vaccine can be a big money maker.